---
title: "Concord Healthcare to Raise HK$68 Million via Convertible Bonds for Debt Repayment and Working Capital"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285858181.md"
description: "Concord Healthcare Group plans to raise HK$68 million through convertible bonds to repay debts and enhance working capital. The bonds will have an initial conversion price of HK$1.70 per share, with net proceeds estimated at HK$63.1 million. Approximately 70% of the funds will be allocated for loan repayment, while 30% will support working capital. The company will seek listing approval for the conversion shares, and the transaction is subject to conditions. Concord Healthcare operates in the healthcare sector and is listed in Hong Kong under stock code 2453."
datetime: "2026-05-11T00:08:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285858181.md)
  - [en](https://longbridge.com/en/news/285858181.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285858181.md)
---

# Concord Healthcare to Raise HK$68 Million via Convertible Bonds for Debt Repayment and Working Capital

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest update is out from Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ).

Concord Healthcare Group plans to issue HK$68 million of convertible bonds under its existing general mandate, with an initial conversion price of HK$1.70 per share and conversion shares ranking pari passu with existing stock. While the bonds themselves will not be listed, the company will seek listing approval for the conversion shares, and the allotment remains within its approved mandate, meaning no additional shareholder vote is required.

Net proceeds are estimated at about HK$63.1 million, implying a net issue price of roughly HK$1.58 per potential conversion share after expenses. Around 70% of the funds will be used to repay loans and leasing liabilities, and about 30% will bolster working capital by the end of 2026, which should strengthen the company’s balance sheet, though completion of the transaction remains subject to conditions and may not proceed.

**More about Concord Healthcare Group Co., Ltd. Class H**

Concord Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China with limited liability and listed in Hong Kong under stock code 2453. The group operates in the healthcare sector, providing medical and related services, and raises capital on the Hong Kong capital markets to support its operations and financial structure.

**Average Trading Volume:** 508,121

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$1.17B

For a thorough assessment of 2453 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [02453.HK](https://longbridge.com/en/quote/02453.HK.md)

## Related News & Research

- [Concord Healthcare Completes HK$68 Million Convertible Bond Issue Under General Mandate](https://longbridge.com/en/news/286260367.md)
- [Concord Healthcare Calls April EGM to Approve 2026 Credit Line and Guarantees](https://longbridge.com/en/news/279617956.md)
- [Craneware Tightens Free Float with Latest Share Buyback Tranche](https://longbridge.com/en/news/286044879.md)
- [RBC Capital Sticks to Its Hold Rating for SCHOTT Pharma AG & Co. KGaA (1SXP)](https://longbridge.com/en/news/286214150.md)
- [Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference | BHC Stock News](https://longbridge.com/en/news/286247060.md)